Delphine Saragoussi

896 total citations
34 papers, 630 citations indexed

About

Delphine Saragoussi is a scholar working on Pharmacology, Social Psychology and Experimental and Cognitive Psychology. According to data from OpenAlex, Delphine Saragoussi has authored 34 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 14 papers in Social Psychology and 11 papers in Experimental and Cognitive Psychology. Recurrent topics in Delphine Saragoussi's work include Treatment of Major Depression (18 papers), Mental Health Treatment and Access (14 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (7 papers). Delphine Saragoussi is often cited by papers focused on Treatment of Major Depression (18 papers), Mental Health Treatment and Access (14 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (7 papers). Delphine Saragoussi collaborates with scholars based in France, United States and Denmark. Delphine Saragoussi's co-authors include Benoît Rive, Josep María Haro, Lene Hammer-Helmich, Dominique Milea, François-Xavier Lamy, Maëlys Touya, Bengt Jönsson, Raymond W. Lam, Natalya Danchenko and C. François and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Geriatrics Society and Journal of Affective Disorders.

In The Last Decade

Delphine Saragoussi

33 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Delphine Saragoussi France 13 262 181 161 148 96 34 630
Nicolas Despiégel France 17 302 1.2× 188 1.0× 151 0.9× 88 0.6× 71 0.7× 38 698
Dieter Schoepf Germany 13 109 0.4× 144 0.8× 214 1.3× 67 0.5× 154 1.6× 23 594
S. Leyman Belgium 9 182 0.7× 214 1.2× 130 0.8× 66 0.4× 103 1.1× 17 495
Katherine Clarke United Kingdom 7 104 0.4× 152 0.8× 75 0.5× 106 0.7× 166 1.7× 19 473
Hannah Myles Australia 16 166 0.6× 94 0.5× 491 3.0× 151 1.0× 330 3.4× 27 1.0k
Maëlys Touya United States 11 110 0.4× 80 0.4× 368 2.3× 81 0.5× 86 0.9× 29 593
Nicholas Myles Australia 14 109 0.4× 68 0.4× 404 2.5× 103 0.7× 231 2.4× 17 738
Sang-Yeol Lee South Korea 17 72 0.3× 106 0.6× 189 1.2× 136 0.9× 284 3.0× 106 867
Brian Berman United States 9 177 0.7× 128 0.7× 189 1.2× 100 0.7× 505 5.3× 14 1.1k
Peter Classi United States 12 75 0.3× 85 0.5× 242 1.5× 49 0.3× 92 1.0× 32 624

Countries citing papers authored by Delphine Saragoussi

Since Specialization
Citations

This map shows the geographic impact of Delphine Saragoussi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delphine Saragoussi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delphine Saragoussi more than expected).

Fields of papers citing papers by Delphine Saragoussi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delphine Saragoussi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delphine Saragoussi. The network helps show where Delphine Saragoussi may publish in the future.

Co-authorship network of co-authors of Delphine Saragoussi

This figure shows the co-authorship network connecting the top 25 collaborators of Delphine Saragoussi. A scholar is included among the top collaborators of Delphine Saragoussi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delphine Saragoussi. Delphine Saragoussi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saragoussi, Delphine, et al.. (2021). Genetic Testing in Natural History Studies: A Review of the Regulatory and Legal Landscape. Public Health Genomics. 24(3-4). 75–88.
2.
Haro, Josep María, Lene Hammer-Helmich, Delphine Saragoussi, Anders Ettrup, & Klaus Groes Larsen. (2019). <p>Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study</p>. Neuropsychiatric Disease and Treatment. Volume 15. 2313–2323. 21 indexed citations
3.
Haro, Josep María, François-Xavier Lamy, Bengt Jönsson, et al.. (2018). Characteristics of patients with depression initiating or switching antidepressant treatment: baseline analyses of the PERFORM cohort study. BMC Psychiatry. 18(1). 80–80. 6 indexed citations
4.
Lamy, François-Xavier, et al.. (2017). The use of adjunctive antipsychotics to treat depression in UK primary care. Current Medical Research and Opinion. 33(5). 891–898. 7 indexed citations
5.
Saragoussi, Delphine, Maëlys Touya, Josep María Haro, et al.. (2017). Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study. Neuropsychiatric Disease and Treatment. Volume 13. 2151–2165. 46 indexed citations
6.
Haro, Josep María, et al.. (2017). Depression severity and cognitive symptoms are independent predictors of functioning in patients with depression. European Neuropsychopharmacology. 27. S806–S806. 2 indexed citations
7.
Lamy, François-Xavier, et al.. (2015). Pharmacotherapeutic strategies for patients treated for depression in UK primary care: a database analysis. Current Medical Research and Opinion. 31(4). 795–807. 4 indexed citations
8.
Lam, Raymond W., et al.. (2013). Psychometric Validation of Perceived Deficits Questionnaire – Depression (PDQ-D) in Patients with Major Depressive Disorder (MDD). Value in Health. 16(7). A330–A330. 37 indexed citations
9.
Boulenger, J.P., et al.. (2013). The Burden of Treatment Change in Major Depressive Disorder: Comparison of Switch Versus Non-Switch Patients in the Perform Study. Value in Health. 16(7). A543–A543. 1 indexed citations
10.
Saragoussi, Delphine, Josep María Haro, J.P. Boulenger, et al.. (2013). Patient-Reported Cognitive Dysfunction Negatively Impacts Functioning in Patients with Major Depressive Disorder – Preliminary Findings from the Perform Study. Value in Health. 16(7). A543–A544. 7 indexed citations
11.
Saragoussi, Delphine, et al.. (2013). A Clinical Research Practice Datalink Analysis of Antidepressant Treatment Patterns and Health Care Costs in Generalized Anxiety Disorder. Value in Health. 16(8). 1133–1139. 9 indexed citations
12.
Saragoussi, Delphine, et al.. (2012). Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study. International Journal of Clinical Practice. 66(11). 1079–1087. 24 indexed citations
13.
Saragoussi, Delphine, et al.. (2011). Comparing Antidepressant Treatment Patterns in Older and Younger Adults: A Claims Database Analysis. Journal of the American Geriatrics Society. 59(7). 1197–1205. 27 indexed citations
14.
Saragoussi, J J, et al.. (2011). Qualité de vie après LASIK : partie II. Qualité de vie et satisfaction d’une population de patients opérée par LASIK. Journal Français d Ophtalmologie. 34(5). 294–302. 7 indexed citations
15.
François, C., Nicolas Despiégel, Khaled Maman, Delphine Saragoussi, & Pascal Auquier. (2010). Anxiety disorders, major depressive disorder and the dynamic relationship between these conditions: treatment patterns and cost analysis. Journal of Medical Economics. 13(1). 99–109. 18 indexed citations
16.
Ereshefsky, Larry, Delphine Saragoussi, Nicolas Despiégel, et al.. (2010). The 6-month persistence on SSRIs and associated economic burden. Journal of Medical Economics. 13(3). 527–536. 22 indexed citations
17.
Saragoussi, Delphine, et al.. (2010). Modeling stroke management: a qualitative review of cost-effectiveness analyses. The European Journal of Health Economics. 11(4). 419–426. 9 indexed citations
18.
Kovess–Masféty, Viviane, Delphine Saragoussi, Christine Sévilla-Dedieu, et al.. (2007). What makes people decide who to turn to when faced with a mental health problem? Results from a French survey. BMC Public Health. 7(1). 188–188. 63 indexed citations
19.
Saragoussi, Delphine & J J Saragoussi. (2004). Lasik, photokéractectomie réfractive et qualité de vision : étude des facteurs pronostiques et enquête de satisfaction. Journal Français d Ophtalmologie. 27(7). 755–764. 6 indexed citations
20.
Conley, Mary Ellen, Delphine Saragoussi, Luigi D. Notarangelo, Amos Etzioni, & Jean‐Laurent Casanova. (2003). An international study examining therapeutic options used in treatment of Wiskott–Aldrich syndrome. Clinical Immunology. 109(3). 272–277. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas Despiégel Breakdown of academic impact, for papers by Dieter Schoepf Breakdown of academic impact, for papers by S. Leyman Breakdown of academic impact, for papers by Katherine Clarke Breakdown of academic impact, for papers by Hannah Myles Breakdown of academic impact, for papers by Maëlys Touya Breakdown of academic impact, for papers by Nicholas Myles Breakdown of academic impact, for papers by Sang-Yeol Lee Breakdown of academic impact, for papers by Brian Berman Breakdown of academic impact, for papers by Peter Classi
Rankless by CCL
2026